Onconomics RGCC Test

Onconomics RGCC Test
What are Identified ?
CTCs (Circulating-Tumor-Cells) , Drug Sensitivity, Genomic profiling.
Test Duration
21 – 25 days *
Test Type
Primary Assessment
Sample required
Blood sampleCancer Type
All type of CancersBlood sample Qty
15-20 ml peripheral whole bloodSample Test Report
DESCRIPTION
ONCONOMICS TEST, provides the detailed report on how effective specific anti-cancer treatments (cytotoxic drugs, monoclonal antibodies, small molecule that inhibitor specific targets (TKI etc.) are targeting Tumour Cells..
This Test also includes the report of the Genetic Profiling of each and every individuals tumour related Genes at epigenetic level to understand nature of cancer disease.
The combination of epigenetic analysis and viability assays results will help the doctors to identify effective treatment plan in treating the cancer for Personalised Cancer Treatments.
SPECIMEN REQUIREMENT
15 ml of whole blood
Chemo Drugs List
Resistance Factors
Tumour Related Genes
Monoclonal Antibodies (MAB's) LIST
Small Molecular Weight Molecules (SMW)
Chemo Drugs List
Alkylating Agents
- Cisplatin
- Carboplatin
- Cyclophosphamide
- Ifosfamide
- Dacarbazine
- Oxaliplatin
- Mitomycin
- Treosulfan
- Temozolomide
- Procarbazine
- BCNU
- ACNU
- CCNU
- Bleomycin
- Melphalan
- Trofosfamidee
- Estramustine
- Bendamustine
- Nedaplatin
- Chlorambucil
- Hydroxyurea
- Altretamine
Epothilones
- Ixabepilone
Inhibitors of Topoisomerase I
- CPT11
- Topotecan
- Gimatecan
Inhibitors of Topoisomerase II
- Doxorubicin
- Liposomal_doxorubicin
- Epirubicin
- Daunorubicin
- Dactinomycin
- Idarubicin
- Etoposide
- Mitoxandrone
- Amrubicin_hydrochloride
Nucleus Spindle Stabilizer I
- Paclitaxel
- Docetaxel
- Eribulin
- Abraxane
- Cabazitaxel
Nucleus Spindle Stabilizer II
- Vincristine
- Vinblastine
- Vinorelbine
Nucleoside Analogues
- 5FU
- MTX
- Gemcitabine
- Capecitabine
- Fudr
- UFT
- Raltitrexed
- Pemetrexed
- Cytarabine
- Fludarabine
Resistance Factors
- MDR 1
- MRP
- LRP
- GST
Tumour Related Genes
- H-TERT
- Bcr-abl
- c-erb-B2
- c-erb-B1
- MTor
- Ras-Raf-MEK-Erk
- Nm23
- KISS-1-r
- Bcl-2
- Histone-deacetylase-dipeptide
- CypB1
- EGF
- TGF-b
- RET
- 06-methyltransferase I
- ALK
- EML – 4 – ALK
- NPM – ALK
- CD 117 (c-Kit)
- IGF – r – 1
- IGF – r- 2
- NR3C4-A
- NR3C4-B
- HSP90
- HSP72
- HSP27
- CES1-2
- HDAC
- HAT ANG1
- ANG2
- PARP (1 to 17)
- BCL-2
- CDK4\CDK6
- DLL3
- C-MET
- DNA-demethylase
- DNA methyltransferase I
- Ribonucleoside reductase
- IkB(a,b,c)
- NFkB
- GARFT
- SHMT
- DHFR
- TS
- MMP
- 5-LOX
- COX2
- PDGF
- FGF
- VEGF
- P16
- P53
- Gamma GC
- TP
- NP
- UP
- DPD
- P27
- Pl80
- E2Fl
- CES1-2
- Estrogen-Receptor
- Progesterone-Receptor
- SS-r
- HSP90
- RRMl
- CXCR4
- CXCR12
- CXCL12
- Bax
- CD95(fas-r)
- JAK 1/2
- 67LR
- PTEN
- c-Jun
- c-Fos
- ERCCl
Monoclonal Antibodies (MAB's) LIST
- Alemtuzumab
- Atezolizumab
- Avelumab
- Bevacizumab
- Brentuximab vedotin
- Catumaxumab
- Cetuximab
- Gemtuzumab
- Ibritumomab(Zevalin)
- Ipilimumab
- Nivolumab
- Ofatumumab
- Panitumumab
- Pembrolizumab
- Pertuzumab
- Ramucirumab
- Rituximab
- Tositumomab(Bexxar)
- Transtuzumab
Small Molecular Weight Molecules (SMW)
- Erlotinib
- Regorafenib
- Goserelin
- Antiandrogen(goserelin)
- Leprolide
- Abiraterone
- Sorafenib
- Everolimus/Temsirolimus
- Sunitinib
- Fulvestrant
- Tamoxifen
- Anastrozol
- Exemestane
- Gefitinib)
- 5-azacytidine
- Pazopanib
- Octreotide
- Axitinib
- Vemurafenib
- Trabectedin
- Crizotinib
- Ruxolitinib
- Imatinib-mesylate
- Nilotinib
- Dasatinib
- Vorinostat
- Olaparib
- Semaxanib
- Lapatinib
- Vandetanib
- Tramentinib
- Dabrafenib
- Palbociclib
- Afatinib
- Niraparib
- Veliparib
- Ponatinib
- Osimertinib
- Nintedanib
- Ziv-Aflibercept